Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Debt Repayments (2023)

Dianthus Therapeutics (DNTH) has 1 years of Long-Term Debt Repayments data on record, last reported at $377000.0 in Q1 2023.

  • For Q1 2023, Long-Term Debt Repayments changed N/A year-over-year to $377000.0; the TTM value through Dec 2023 reached $377000.0, changed N/A, while the annual FY2023 figure was $377000.0, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $377000.0 in Q1 2023 per DNTH's latest filing.
  • Across five years, Long-Term Debt Repayments topped out at $377000.0 in Q1 2023 and bottomed at $377000.0 in Q1 2023.